Novavax Inc (NVAX)

[BigBake1]

Well the big players were right, instead of following the rest of the market last week in buying up the news of the Fast Track and Ebola vaccine, they stayed out with earning right around the corner. The analyst were calling for -.068 and actual were -.08, so it missed on yet another quarter.

That was the only bad news, the rest is all good news, overall revenues are better from last year by 71% for the same quarter. The pipeline looks good as well with many trials coming to conclusion and new ones about to start. No concern over money, plenty of cash on hand, recent BARDA put $70 million more out there, no need for future capital raises in the near future.

Stock has risen to $5.34 in after hours trading. Looking at the chart it is obvious this move was technically based as the gap created by the Ebola news was completely closed out today and the over all volume has been relatively low.